US 9169509
Topoisomerase 2b as a predictor of susceptibility to anthracycline-induced cardiotoxicity
granted A61KA61K31/704
Quick answer
US patent 9169509 (Topoisomerase 2b as a predictor of susceptibility to anthracycline-induced cardiotoxicity) held by The Board of Regents of the University of Texas System expires Mon Oct 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Oct 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K31/704